Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
It is a modified GHRH(1-29) analog designed to resist enzymatic breakdown and extend duration of action through albumin binding. Key features of CJC-1295 DAC CJC-1295 with DAC: Activates the GHRH receptor on pituitary somatotroph cells Stimulates endogenous GH release Increases downstream IGF-1 signaling Binds to albumin through the DAC structure Produces sustained GH/IGF-1 effects over multiple days Because of this extended exposure, CJC-1295 DAC is usually discussed in research contexts focused on longer-duration GH-axis activation rather than short GH pulses
They are particularly useful when analyzing lipidated peptides or detecting trace-level impurities
For the scenario of "Proven Treatment Today," research data suggests Semaglutide may be more relevant
Received: Revised: Accepted: Published: Issue date: DOI:
US$ 25.33
US$ 27.81
US$ 21.60
